{
  "id": 5617513,
  "title": "AltraFlowSOM: A Semi-Supervised Framework for Imaging Mass Cytometry Phenotyping",
  "url": "https://urgent.news/2026/09/04/altraflowsom-a-semi-supervised-framework-for-imaging-mass-cytometry",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-04T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.08.31.748226v1?rss=1"
  },
  "original_language": "en",
  "account": "Imaging Mass Cytometry (IMC) allows for the simultaneous quantification of multiple protein markers within individual cells in tissue samples. However, accurately phenotyping cells at scale remains a significant challenge. Traditional unsupervised clustering methods often fail to maintain coherent populations, while supervised classifiers impose limitations on the vocabulary of cell types. Rare cell subtypes, which may encode clinically relevant information, can also negatively impact detection performance when combined with abundant cell types.\n\nThe research team introduces AltraFlowSOM, a semi-supervised framework built upon the FlowSOM algorithm. AltraFlowSOM incorporates expert annotations into the self-organizing map training process using a two-layer SuperSOM architecture. This approach balances the guidance provided by labeled reference points with the unsupervised discovery of cell populations.\n\nBy anchoring the map to biologically labeled points, AltraFlowSOM eliminates the need for batch correction before clustering. In a study comparing AltraFlowSOM to unsupervised and supervised baselines on two independent IMC cohorts - Lupus Nephritis (n=22 ROIs) and Sjogren syndrome (n=10 ROIs) - the semi-supervised method outperformed all other approaches. Metrics such as Adjusted Rand Index, F1 scores (both macro and weighted), weighted purity, and the identification of rare cell populations were significantly improved with AltraFlowSOM.\n\nOne of the most notable findings was the median Treg cell recovery, which surpassed that of all other methods. The study demonstrates that AltraFlowSOM effectively resolves the scalability-alignment-discovery trilemma in high-dimensional IMC phenotyping by offering a generalizable semi-supervised SOM framework.",
  "summary": "Imaging Mass Cytometry (IMC) enables the simultaneous quantification of 40+ protein markers at single cell resolution in tissue, however biologically faithful phenotyping at scale remains a critical bottleneck. Unsupervised clustering fragments coherent populations or conversely merges biologically incoherent ones into a single cluster, supervised classifiers impose a closed vocabulary, and the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}